110 related articles for article (PubMed ID: 35972694)
21. Deconvolution of immune cell composition and biological age of hepatocellular carcinoma using DNA methylation.
Jain SS; McNamara ME; Varghese RS; Ressom HW
Methods; 2023 Oct; 218():125-132. PubMed ID: 37574160
[TBL] [Abstract][Full Text] [Related]
22. RNA processing modification mediated subtypes illustrate the distinctive features of tumor microenvironment in hepatocellular carcinoma.
Li X; Liu S; Zou L; Dai M; Zhu C
Genes Immun; 2024 Apr; 25(2):132-148. PubMed ID: 38472339
[TBL] [Abstract][Full Text] [Related]
23. Role of N6-Methyladenosine (m
Qu N; Bo X; Li B; Ma L; Wang F; Zheng Q; Xiao X; Huang F; Shi Y; Zhang X
Front Oncol; 2021; 11():755206. PubMed ID: 34692544
[TBL] [Abstract][Full Text] [Related]
24. Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors.
Zeng Y; Yu T; Lou Z; Chen L; Pan L; Ruan B
Pathol Res Pract; 2024 Apr; 256():155268. PubMed ID: 38547773
[TBL] [Abstract][Full Text] [Related]
25. RNA m6A modifications regulate crosstalk between tumor metabolism and immunity.
Gu J; Cao H; Chen X; Zhang XD; Thorne RF; Liu X
Wiley Interdiscip Rev RNA; 2024; 15(1):e1829. PubMed ID: 38114887
[TBL] [Abstract][Full Text] [Related]
26. IGF2BP2-related modification patterns in pancreatic cancer: A machine learning-driven approach towards personalized treatment.
Chen D; Zang L; Zhou Y; Yang Y; Zhang X; Li Z; Shu Y; Gao W; Zhu H; Yu X
Heliyon; 2024 Mar; 10(6):e28243. PubMed ID: 38545193
[TBL] [Abstract][Full Text] [Related]
27. Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies.
Zhu LR; Ni WJ; Cai M; Dai WT; Zhou H
Front Cell Dev Biol; 2021; 9():777007. PubMed ID: 34778277
[TBL] [Abstract][Full Text] [Related]
28. Nurturing gut health: role of m6A RNA methylation in upholding the intestinal barrier.
Wang S; Yang Y; Jiang X; Zheng X; Wei Q; Dai W; Zhang X
Cell Death Discov; 2024 Jun; 10(1):271. PubMed ID: 38830900
[TBL] [Abstract][Full Text] [Related]
29. Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies.
Xuan Z; Song J; Yang Q; Huang P
Front Immunol; 2023; 14():1322220. PubMed ID: 38022560
[No Abstract] [Full Text] [Related]
30. Correction: N7‑methylguanosin regulators‑mediated methylation modification patterns and characterization of the immune microenvironment in lower‑grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2024 Jan; 29(1):59. PubMed ID: 38243305
[No Abstract] [Full Text] [Related]
31. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.
Peng WX; Liu F; Jiang JH; Yuan H; Zhang Z; Yang L; Mo YY
Genes Dis; 2023 Mar; 10(2):554-567. PubMed ID: 37223505
[TBL] [Abstract][Full Text] [Related]
32. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
33. Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma.
Zhang C; Dai D; Zhang W; Yang W; Guo Y; Wei Q
J Gastroenterol Hepatol; 2022 Nov; 37(11):2039-2050. PubMed ID: 36066844
[TBL] [Abstract][Full Text] [Related]
34. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
[TBL] [Abstract][Full Text] [Related]
35. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma.
Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694
[TBL] [Abstract][Full Text] [Related]
36. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Huang X; Qiu Z; Li L; Chen B; Huang P
Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
[TBL] [Abstract][Full Text] [Related]
37. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.
Xu H; Yin L; Xu Q; Xiang J; Xu R
Cancer Cell Int; 2022 May; 22(1):199. PubMed ID: 35606813
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
